Disease: Prostatic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.360 Biomarker group BEFREE The antitumor effect of CYP1B1 shRNA was also observed in prostate tumor xenograft mouse models. 28388569 2017
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.360 AlteredExpression group BEFREE CYP1B1 expression has been reported to be higher in tumors compared to normal tissues, especially in hormone-related cancers including breast, ovary, and prostate tumors. 26981862 2016
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.360 GeneticVariation group LHGDN CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians. 18544568 2008
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.360 Biomarker group LHGDN Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel. 18187806 2008
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.360 Biomarker group CTD_human Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. 17704407 2007
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.360 PosttranslationalModification group LHGDN Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. 16115918 2005
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.360 GeneticVariation group LHGDN Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer. 12200121 2002